Rutschmann O T, Wicki J, Micheli P, Kondo Oestreicher M, Guillermin Spahr M L, Droz M
Département de médecine interne, Hôpitaux universitaires de Genève. Olivier.Rutschmann/hcuge.ch
Schweiz Med Wochenschr. 1998 Aug 4;128(31-32):1171-4.
We report a case of severe hypoglycaemia following co-trimoxazole therapy. An 88-year-old woman was admitted with urinary tract infection and treated with co-trimoxazole (960 mg bid). Seven days after initiation of the treatment she became comatose. Blood sugar was 1.3 mmol/l and C-peptide at the upper limit of normal range. Glucose infusion restored normal consciousness and no hypoglycaemia recurred after interruption of co-trimoxazole therapy. Advanced aged was the only risk factor identified. Other risk factors described in previous case reports are renal failure, poor nutritional state and high doses of co-trimoxazole.